Cleared Traditional

SuperCross microcatheter, SuperCross FT microcatheter, SuperCross AT microcatheter (K210647) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K210647 · Vascular Solutions, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2021
Decision
58d
Days
Class 2
Risk

K210647 is an FDA 510(k) clearance for the SuperCross microcatheter, SuperCross FT microcatheter, SuperCross AT microcat.... Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Vascular Solutions, LLC (Minneapolis, US). The FDA issued a Cleared decision on April 30, 2021 after a review of 58 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Vascular Solutions, LLC devices

Submission Details

510(k) Number K210647 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 03, 2021
Decision Date April 30, 2021
Days to Decision 58 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 125d · This submission: 58d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 320
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K210647.
Arterial Catheter
K201726 · Haolang Medical USA Corporation · Jul 2021
coraCross
K210188 · Reflow Medical · May 2021
ViperCath XC Peripheral Exchange Catheter
K211251 · Cardiovascular Systems, Inc. · May 2021
Plato 17 Microcatheter
K210601 · Scientia Vascular, LLC · Apr 2021
Guidion
K210110 · Imds Operations B.V. · Mar 2021
FineCross M3
K203521 · Ashitaka Factory of Terumo Corporation · Mar 2021